Evidence map›Paper›PMID 41099279›Full record

ArticlePhotochemistry and photobiology

Multifaceted Ru(II) arene systems for phototherapy display activity in lung cancer and melanoma.

Joseph Spiconardi, Dmytro Havrylyuk, Ge Shi, Alisher Talgatov, Colin G Cameron, David K Heidary, Sherri A McFarland, Edith C Glazer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joseph SpiconardiDepartment of Chemistry, North Carolina State University, Raleigh, North Carolina, USA.ORCID 0009-0007-0166-6209
Dmytro HavrylyukDepartment of Chemistry, North Carolina State University, Raleigh, North Carolina, USA.ORCID 0000-0001-7766-9923
Ge ShiDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, USA.ORCID 0000-0001-7469-1834
Alisher TalgatovDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, USA.ORCID 0000-0002-9421-6878
Colin G CameronDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, USA.ORCID 0000-0003-0978-0894
David K HeidaryDepartment of Chemistry, North Carolina State University, Raleigh, North Carolina, USA.ORCID 0000-0001-6008-4216
Sherri A McFarlandDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, USA.ORCID 0000-0002-8028-5055
Edith C GlazerDepartment of Chemistry, North Carolina State University, Raleigh, North Carolina, USA.ORCID 0000-0002-0190-7742

Funding

Light-responsive ruthenium compounds for applications in diseaseR01GM107586 · NIGMS · UNIVERSITY OF KENTUCKY · PI GLAZER, EDITH C · 2014 to 2019
$1.7M
National Science Foundation 2333820National Science Foundation 2400127NIGMS NIH HHS GM107586NIGMS NIH HHS R01 GM107586
6 · The paper itself

Abstract

Phototherapy approaches include photodynamic therapy (PDT), which utilizes chemically stable photocatalysts to sensitize the conversion of endogenous molecules such as oxygen (O

Indexed as

Lung NeoplasmsMelanomaPhotosensitizing AgentsRutheniumCell Line, TumorHumansPhotochemotherapyPhotosensitizing AgentsRutheniumhypoxialung cancermelanomaoligothiophenephotodynamic therapyphotopharmacologyphotosubstitutionROS

Identifiers

PMID41099279
PMCPMC13244303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.